Research Suggests Home Environment Impacts Disease Outcomes, Symptom Control

Pharmacists routinely counsel patients on medications, lifestyle changes, and adherence strategies for chronic disease management. But what if another therapeutic tool has been sitting in plain sight all along? A patient’s home environment may influence symptom burden, treatment response, and quality of life more than previously understood.

A new perspective article published in Healthcare introduces the concept of a therapeutic home environment as an adjunctive strategy for managing difficult-to-treat chronic conditions, including chronic migraine, anxiety, chronic pain, insomnia, and treatment-resistant depression. Researchers suggest that the physical environment in which patients live may meaningfully affect disease outcomes and long-term symptom control.¹

The proposed model focuses on 3 interrelated elements, including biophilic design, indoor environmental quality, and intentional self-care spaces. Biophilic design refers to incorporating nature into living spaces through plants, natural materials, lighting, and outdoor views. Indoor environmental quality includes factors such as lighting, air quality, and noise exposure. Intentional self-care spaces are areas of the home designed to encourage restorative habits such as sleep, exercise, mindfulness, or relaxation.¹ Several clinically relevant themes can be important for pharmacists.

Sleep quality appears particularly important across chronic disease states. Sleep disruption contributes to migraine, anxiety, chronic pain, and mood disorders. Pharmacists counseling on medications for these conditions can reinforce healthy sleep habits by discussing consistent sleep schedules, reducing evening screen exposure, and identifying medication-related contributors to insomnia.¹

Environmental triggers may also affect disease control more than providers appreciate. Excessive noise, poor air quality, lighting disturbances, and sensory overstimulation may worsen symptoms in susceptible individuals. Pharmacists may consider asking patients whether symptoms worsen during periods of stress, poor sleep, or changes in their environment.¹

The review also reinforces the importance of multimodal care. Medications remain central to disease management, but pharmacotherapy alone may not always provide sufficient symptom control. Self-care practices such as stress management, physical activity, mindfulness, and patient education may complement evidence-based treatment plans and improve outcomes.¹

Although migraine serves as a major focus of the paper, the broader message extends to many chronic conditions. Patients do not experience illness separately from their surroundings. For pharmacists, even brief conversations about sleep, stress, and daily habits may help patients manage chronic disease better and improve therapeutic success.

REFERENCE

Huntsman DD, Jenkinson D, Bulaj G. The therapeutic home environment for chronic diseases: a transdisciplinary ecosystem for achieving migraine freedom and managing comorbid anxiety, insomnia, and chronic pain. Healthcare. 2026;14(9):1123. doi:10.3390/healthcare14091123.